Farallon Capital Management LLC Tyme Technologies, Inc. Transaction History

Farallon Capital Management LLC

  • $20.7 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$2.01 - $4.21 $211,049 - $442,050
-105,000 Reduced 25.87%
300,857 $1.11 Million
Q3 2018

Nov 14, 2018
SELL
$2.18 - $3.44 $1.18 Million - $1.87 Million
-542,533 Reduced 57.21%
405,857 $1.13 Million
Q2 2018

Aug 14, 2018
SELL
$2.05 - $4.09 $987,892 - $1.97 Million
-481,899 Reduced 33.69%
948,390 $3 Million
Q1 2018

May 15, 2018
BUY
$2.12 - $7.0 $3.03 Million - $10 Million
1,430,289 New
1,430,289 $3.19 Million

About TYME TECHNOLOGIES, INC.

TYME Quotes by TradingView
  • Ticker TYME
  • Exchange NASDAQ
  • Shares Outstandng 172,207,008
  • Description
  • Tyme Technologies, Inc., a biotechnology company, develops cancer metabolism-based therapies (CMBTs) in the United States. Its lead drug product is SM-88, a CMBT that is in a Phase II/III clinical trial to treat across 15 types of cancer, including pancreatic, prostate, breast, lung, glioma, ovarian, sarcoma, and colon. The company is also devel...
More about TYME
Track This Portfolio

Track Farallon Capital Management LLC Portfolio

Follow Farallon Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farallon Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email